- £21.73m
- £29.99m
- £7.25m
- 43
- 57
- 59
- 52
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20.4 | 16.3 | 12.1 | 8.64 | 7.25 |
Cost of Revenue | |||||
Gross Profit | 15.9 | 12.3 | 7.99 | 5.72 | 4.99 |
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11.9 | 11.1 | 17.2 | 2.58 | 5.25 |
Operating Profit | 8.5 | 5.23 | -5.07 | 6.06 | 2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.31 | 5.52 | -5.09 | 7.08 | 2.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.37 | 4.91 | -7.4 | 6.83 | 2.04 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.51 | 4.86 | -7.45 | 6.78 | 1.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 5.52 | 4.87 | -7.45 | 6.78 | 1.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.016 | 0.043 | -0.067 | 0.015 | 0.017 |
Dividends per Share |